ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News
Photo:

Silver Investment Partners acquires specialty pharmaceutical distributor Lucien Ortscheit

19. May 2020

Saarbrücken/ Frank­furt a. Main — Silver Invest­ment Part­ners (SIP) acqui­res specialty phar­maceu­ti­cal distri­bu­tor Lucien Ortscheit. King & Wood Malle­sons (KWM) advi­sed Silver Invest­ment Part­ners (SIP) on the acqui­si­tion of a majo­rity stake in Lucien Ortscheit GmbH (Lucien Ortscheit).

Lucien Ortscheit, based in Saar­brü­cken, Germany, is a leading inter­na­tio­nal specialty phar­maceu­ti­cal distri­bu­tor with a focus on unli­cen­sed medi­ci­nes and clini­cal trial compa­ra­tors. The company trades world­wide in medi­ci­nes that are tempo­r­a­rily unavailable or unap­pro­ved in the target coun­try. Lucien Ortscheit was foun­ded in 1963 and taken over by the Kloos family in 2002. Since its foun­da­tion, the company has steadily deve­lo­ped and today alre­ady counts seve­ral thousand custo­mers from over 60 count­ries among its widely diver­si­fied and loyal custo­mer base.

SIP is an inde­pen­dent inves­tor for equity finan­cing of medium-sized compa­nies in Germany, Austria and Switz­er­land. As an entre­pre­neu­rial, expe­ri­en­ced and relia­ble part­ner, SIP is invol­ved in majo­rity and mino­rity invest­ments in compa­nies with sales between 5 and 100 million euros, with a focus on compa­nies with sales between 10 and 50 million euros.

The previous owners, the Kloos family, will retain a mino­rity stake in the company. Mr. Kloos will conti­nue to be respon­si­ble for the opera­tio­nal busi­ness as Mana­ging Direc­tor in the medium term. SIP supports Lucien Ortscheit’s sustainable growth stra­tegy. To further deve­lop the company, growth oppor­tu­ni­ties such as inter­na­tio­nal expan­sion, expan­sion of the product range and further suita­ble acqui­si­ti­ons in the natio­nal and inter­na­tio­nal attrac­tive niche market are to be exploited.

Advi­sors Silver Invest­ment Part­ners: King & Wood Mallesons
Dr. Michael Roos (Part­ner), Dr. Peter Polke (Coun­sel), Dr. Katrin Thoma (Asso­ciate), Lorenz Liebsch (Asso­ciate), Simon Brandt (PSL) (all Corporate/M&A);
Markus Hill (Part­ner), Vikto­ria Rosbach (Asso­ciate) (both Tax)

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de